CXCL12 and breast carcinoma: Although CXCL12 signaling seems to exert rather harmful effects on adaptive immunity in breast cancer, one study reported the opposite observations: CXCL12 overexpression in mouse breast cancer cells was found to induce the CD8+ T cells response and to boost the T cell-mediated cytotoxicity [80].